By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Genzyme Corporation 

500 Kendall Street

Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-252-7500 Fax: 617-252-7600


SEARCH JOBS

About Genzyme

Genzyme is committed to discovering and delivering transformative therapies for patients with rare and special unmet medical needs, providing hope where there was none before.

Genzyme has pioneered the development and delivery of transformative therapies for over 30 years. Founded in 1981 in Boston, Massachusetts, Genzyme evolved from a tiny start-up with just a handful of employees to one of the world's leading biotech companies. Acquired by Sanofi in 2011, Genzyme now benefits from the reach and resources of one of the world’s largest pharmaceutical companies, with a shared commitment to improving the lives of patients.

Genzyme has long been known for our expertise in the class of rare genetic diseases known as lysosomal storage disorders (LSDs). LSDs remain the heart of our company today, but we have also expanded – through both in-house development and strategic acquisitions and partnerships – to other disease areas such as thyroid cancer and multiple sclerosis.

Learn more at www.jobsatgenzyme.com.

Follow our jobs on Twitter www.twitter.com/genzymejobs.

Follow us on LinkedIn http://www.linkedin.com/company/genzyme.

About Sanofi

Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets, and animal health. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).


Key Statistics


Email: AskGenzyme@genzyme.com
Ownership: Public

Web Site: Genzyme Corporation
Employees:
Symbol: GENZ
 



Industry
Biotechnology


Collaborations

Medtronic, Inc.  Cardiac Cell Therapy

Cambridge Antibody Technology Group PLC   Antibodies against TGF-ß

Dyax Corp.  Hereditary Angioedema





Company News
Genzyme Corporation (GENZ)’s Lemtrada Approved In Argentina For Treatment Of Multiple Sclerosis 6/30/2014 8:36:59 AM
Former Genzyme Corporation (GENZ) Subsidiary rEVO Biologics Files For $75 Million IPO 6/30/2014 7:11:44 AM
FDA Will Review Genzyme Corporation (GENZ)'s Lemtrada Resubmission; Agency Action Expected In Q4 2014 5/30/2014 6:27:08 AM
Genzyme Corporation (GENZ) Recognizes Sixth Annual World MS Day 5/28/2014 10:09:00 AM
Genzyme Corporation (GENZ)’s Lemtrada Recommended For Reimbursement On NHS By National Institute for Clinical Excellence (NICE) 5/28/2014 9:12:39 AM
Genzyme Corporation (GENZ) Recognizes Sixth Annual World MS Day 5/28/2014 7:35:58 AM
Genzyme Corporation (GENZ)'s Lemtrada Recommended For Reimbursement On NHS By The National Institute for Clinical Excellence (NICE) 5/28/2014 7:07:55 AM
Boston CEO Conference To Feature Ceos Of Aegerion Pharmaceuticals, Inc. (AEGR), Alkermes plc (ALKS), Alnylam Pharmaceuticals (ALNY), Flex Pharma, Genzyme Corporation (GENZ), Infinity Pharmaceuticals Inc. (INFI), OvaScience (OVAS), Sarepta Therapeutics (SRPT), Tesaro, Inc. (TSRO), Verastem, Inc. (VSTM) And Others June 4th And 5th 5/20/2014 7:03:42 AM
Genzyme Corporation (GENZ) And Isis Pharmaceuticals, Inc. (ISIS) Receive Corporate Award From The National Organization For Rare Disorders (NORD) For The Development Of KYNAMRO® 5/8/2014 12:43:05 PM
NeuralStem Inc. Appoints Sandford Drexel Smith, Former Genzyme Corporation (GENZ) Executive Vice President, To Board Of Directors 5/8/2014 7:34:27 AM
12345678910...
//-->